Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations

AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations

Resource Type

CF Research News

Authors

Rebecca J. Darrah, Frank J. Jacono, Neha Joshi, Anna L. Mitchell, Abdus Sattar, Cara K. Campanaro, Paul Litman, Jennifer Frey, David E. Nethery, Eric S. Barbato, Craig A. Hodges, Harriet Corvol, Garry R. Cutting, Michael R. Knowles, Lisa J. Strug
Mitchell L Drumm

References

J Cyst Fibros. 2018 Jun 21. pii: S1569-1993(18)30618-0. doi: 10.1016/j.jcf.2018.05.013.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Angiotensin signaling [3]
GWAS follow up [4]
Mouse models of airway disease [5]
Pulmonary function [6]

Date

Thursday, June 21, 2018

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/agtr2-absence-or-antagonism-prevents-cystic-fibrosis-pulmonary

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-18-00079R1_FINAL_Darrah_130718.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/29937318 [3] https://www.ecfs.eu/research-article-keywords/angiotensin-signaling [4] https://www.ecfs.eu/research-article-keywords/gwas-follow [5] https://www.ecfs.eu/research-article-keywords/mouse-models-airway-disease [6] https://www.ecfs.eu/research-article-keywords/pulmonary-function [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines